Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: Could the type of surgical resection dictate survival?

Journal of Cardiovascular Surgery

Volumn 44, Issue 1, 2003, Pages 119-123

  Luzzi, Luca ^a   Voltolini, L ^a   Campione, A ^a   Paladini, P ^a   Ghiribelli, C ^a   Di Bisceglie, M ^a   Gotti, G ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Adjuvant therapy; Carcinoma, non small cell lung; Lung neoplasms, surgery; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LARGE CELL CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PLEURA METASTASIS; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0037732632     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yano T, Yokoyama H, Inoue T, Asoh H, Tayama K, Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. J Thorac Cardiovasc Surg 1994;107:1398-402.
2. Martini CF, Burt ME, Bains MS, McCormak PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 1992;54:960-6.
3. Choy O, Jahan T, Roach M, You L, Jablons D. Stage II (N1) lung cancer. Chest Surg Clin North Am 2001;1:39-57.
4. The World Health Organization. Histological typing of lung tumors. 2nd ed. Geneva: World Health Organization; 1981.
5. Montain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
6. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-23.
7. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9.
8. Kaplan El, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-81.
9. Nesbitt JC, Putnam JB, Walsh GL, Roth JA, Mountain CF. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995;60:466-72.
10. Martini N, Flehinger BJ, Zahan MB, Beattie EJ. Results of resection in non oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983;198:386-97.
11. Riquet M, Manac'h D, Le Pimpec-Barthes F, Dujon A, Chehab A. Prognostic significance of surgical pathologic N1 disease in non-small cell lung carcinoma of the lung. Ann Thorac Surg 1999;67:1572-6.
12. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-7.
13. Shields TW. The location of station 10 pulmonary lymph nodes. J Thorac Cardiovasc Surg 1995;109:402-3.
14. Asamura H, Suzuki K, Kondo H, Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer? Ann Thorac Surg 2000;70:1839-46.